Court-Type Thai Traditional Massage for Patients with Intractable Peripheral Neuropathic Pain: a Randomized Controlled Trial
Issued Date
2023-01-01
Resource Type
eISSN
22288082
Scopus ID
2-s2.0-105005539667
Journal Title
Siriraj Medical Journal
Volume
75
Issue
8
Start Page
599
End Page
611
Rights Holder(s)
SCOPUS
Bibliographic Citation
Siriraj Medical Journal Vol.75 No.8 (2023) , 599-611
Suggested Citation
Apichartvorakit A., Euasobhon P., Booranasubkajorn S., Suwannatrai S., Vannabhum M., Rattanawongsamathakul D., Prasartpornsirichoke S., Akarasereenont P., Asavamongkolkul A. Court-Type Thai Traditional Massage for Patients with Intractable Peripheral Neuropathic Pain: a Randomized Controlled Trial. Siriraj Medical Journal Vol.75 No.8 (2023) , 599-611. 611. doi:10.33192/SMJ.V75I8.262655 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/110367
Title
Court-Type Thai Traditional Massage for Patients with Intractable Peripheral Neuropathic Pain: a Randomized Controlled Trial
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Objective: Neuropathic pain management involves both pharmacological and non-pharmacological interventions. Despite this, no prior research has demonstrated the efficacy of court-type Thai traditional massage (CTTM) for neuropathic pain relief. This study aimed to investigate the potential benefits of CTTM in alleviating neuropathic pain. Materials and Methods: A preliminary single-blind randomized controlled trial was conducted on 28 participants with peripheral neuropathic pain, who were equally assigned to 2 groups. Both groups received standard drug treatment; however, the intervention group additionally received CTTM and hot herbal compression, while the active control group only received HHC. The adjuvant treatments were administered twice weekly for 4 weeks (V1-V8). A follow-up was conducted 4 weeks posttreatment (V9). Outcome measures were assessed at V1, V4, V8, and V9 using a numerical rating scale and the Thai versions of the Neuropathic Pain Symptom Inventory, the Brief Pain Inventory, and the EQ-5L-5D health questionnaire. Results: The data revealed that the intervention and active control groups had statistically significant differences in their pain intensity scores (P < 0.001), total neuropathic pain intensity scores (P = 0.001), and utility of health scores (P = 0.007) during the follow-up period. When comparing outcomes between V1 and V8, the groups exhibited significant differences in pain reduction (P = 0.003) and quality of life (P = 0.027). Conclusion: This study provides initial evidence supporting the potential benefits of CTTM in alleviating peripheral neuropathic pain and improving quality of life. Future research should further investigate the application of CTTM in managing peripheral neuropathic pain conditions.